Cite
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.
MLA
Decrem, Yves, et al. “Ir-CPI, a Coagulation Contact Phase Inhibitor from the Tick Ixodes Ricinus, Inhibits Thrombus Formation without Impairing Hemostasis.” The Journal of Experimental Medicine, vol. 206, no. 11, Oct. 2009, pp. 2381–95. EBSCOhost, https://doi.org/10.1084/jem.20091007.
APA
Decrem, Y., Rath, G., Blasioli, V., Cauchie, P., Robert, S., Beaufays, J., Frère, J.-M., Feron, O., Dogné, J.-M., Dessy, C., Vanhamme, L., & Godfroid, E. (2009). Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. The Journal of Experimental Medicine, 206(11), 2381–2395. https://doi.org/10.1084/jem.20091007
Chicago
Decrem, Yves, Géraldine Rath, Virginie Blasioli, Philippe Cauchie, Séverine Robert, Jérôme Beaufays, Jean-Marie Frère, et al. 2009. “Ir-CPI, a Coagulation Contact Phase Inhibitor from the Tick Ixodes Ricinus, Inhibits Thrombus Formation without Impairing Hemostasis.” The Journal of Experimental Medicine 206 (11): 2381–95. doi:10.1084/jem.20091007.